Galectin Therapeutics elects all 11 director nominees, ratifies auditor at 2024 annual meeting

GALECTIN THERAPEUTICS INC

All 11 director nominees elected with votes for ranging from 18.2M to 19.0M; broker non-votes of 20.0M.
Ratification of Cherry Bekaert LLP as auditor: 38.7M for, 162.8K against, 408.9K abstain.
Annual meeting held January 23, 2025; directors elected for term until next annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.